Our Approach
We believe that the combination of advances in biomedical science and information technology provides a unique opportunity to build transformative companies.
Our approach is rooted in bringing together deep market insights and scientific, clinical, and technological expertise.
We endeavor to identify promising businesses where we can help chart a path to build strategically important businesses.
Portfolio Impact
90%
of all clinical trials in the U.S.87%
of all FDA-approved drugs3,000+
hospitals and care providersRecent Perspectives
Portfolio News
Portfolio News
Areas of Focus
We focus on investing in business services companies that can serve as catalysts for transforming the healthcare system.
Pharma Services and Medical Technology
- Clinical Research
- Commercial Enablement
- MedTech Outsourcing
Immune therapy and biologic drug development services
Biosimulation software and technology to transform drug discovery and development
Value demonstration and commercialization services for pharmaceutical companies
Pharmaceutical clinical trial optimization solutions
Healthcare Technology and Services
- Clinical and Economic Optimization
- Employer Health Technology
- Specialty Pharmacy Enablement
WCG Clinical Services
Pharmaceutical clinical trial optimization solutions
View Case StudyCellCarta
Immune therapy and biologic drug development services
View Case StudyHopebridge
Autism therapy services
View Case Study
View Healthcare Portfolio
Team
Strategic Company Builders
Arsenal’s healthcare team brings together world-class bio-medical, information technology, and investment professionals into one integrated team.
Drawing on the industry and technical expertise of over two dozen scientific and medical leaders, the healthcare team is able to guide our portfolio company management teams and help shape market leaders.
Healthcare News & Insights
Portfolio News
Portfolio News
Portfolio News
Portfolio News
Portfolio News
Portfolio News
Portfolio News